logo
Lubrizol Announces an Important Milestone for Its Novel Patented Excipient, Apisolex™ Polymer

Lubrizol Announces an Important Milestone for Its Novel Patented Excipient, Apisolex™ Polymer

Yahoo09-06-2025
CLEVELAND, June 09, 2025--(BUSINESS WIRE)--Lubrizol announces that an Apisolex™ polymer excipient-enabled drug formulation is in Phase 1 clinical trials.
Introduced to the market in 2022, Apisolex polymer excipient is a polyamino acid-based polymer that enhances the solubility of BCS Class II and IV active pharmaceutical ingredients (API). Apisolex polymer excipient is manufactured following Good Manufacturing Practices (GMP) guidelines and can be used in dosage forms for various routes of administration, including parenteral.
The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold. Apisolex polymer excipient is currently being evaluated in multiple programs across the globe, enabling delivery of hard-to-formulate APIs from various therapeutic classes and by multiple routes.
Kevin Song, Senior Director, Global Pharmaceutical and Nutraceutical Business, notes "the progression to clinical trials of a medicinal product formulated with Apisolex polymer excipient demonstrates its ability to provide differentiated solutions to solubility and bioavailability challenges in parenteral formulations." Song adds, "Lubrizol continues to invest in expanding the reach of the Apisolex polymer excipient across global markets and nurturing relationships with drug product manufacturers that are facing insoluble API challenges."
About Lubrizol
Lubrizol, a Berkshire Hathaway company, is a science-based company whose specialty chemistry delivers sustainable solutions to advance mobility, improve well-being and enhance modern life. Every day, the innovators of Lubrizol strive to create extraordinary value for customers at the intersection of science, market needs and business success, driving discovery and creating breakthrough solutions that enhance life and make the world work better. Founded in 1928, Lubrizol has global reach and local presence, with over 100 manufacturing facilities, sales and technical offices and over 7,000 employees worldwide. For more information, visit www.lubrizol.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250609920110/en/
Contacts
MEDIA CONTACT Lori Ditty, Global Marketing ManagerLori.Ditty@Lubrizol.com Lubrizol.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

JoAcademy Partners With Truecaller to Deliver Trusted, Contextual Communication Experience for the Student Ecosystem in Jordan
JoAcademy Partners With Truecaller to Deliver Trusted, Contextual Communication Experience for the Student Ecosystem in Jordan

Business Wire

time7 hours ago

  • Business Wire

JoAcademy Partners With Truecaller to Deliver Trusted, Contextual Communication Experience for the Student Ecosystem in Jordan

BUSINESS WIRE)-- JoAcademy, Jordan's leading e-learning platform, has joined hands with Truecaller, the leading global communications platform to enhance how it connects with its student community. The collaboration focuses on strengthening trust and clarity in customer communication by integrating Truecaller Customer Experience Solution. In a digital learning environment, seamless and credible communication is essential. JoAcademy is now using Truecaller Customer Experience Solution to ensure that students, parents, and users instantly recognize when the call is coming from the official JoAcademy team. With the business name displayed in Arabic and verified branding, confusion and hesitation around unknown numbers are eliminated. Beyond verification, JoAcademy has enabled the Call Reason capability with localisation in Arabic, allowing the team to communicate the purpose of the call upfront. Whether it's a course recommendation, a payment reminder, or a quick check-in from support, users now know exactly why they're being contacted, bringing clarity and reducing friction. In addition, JoAcademy is using other capabilities from the Truecaller Customer Experience suite to enhance its communication further. With Video Caller ID, each call is visually branded, making interactions more engaging and instantly recognizable. The Call Me Back capability empowers students to respond at their convenience in case they miss a call and suggest the time slot they want to get a call back. Additionally, the User Feedback capability allows JoAcademy to gather real-time input from users, helping the team continuously refine and improve the overall service experience. Commenting on the partnership, Alaa Jarrar, CEO at Jo Academy, said: "At JoAcademy, students are at the heart of everything we do. Trust and clarity in communication are essential pillars of a successful learning experience. Our partnership with Truecaller for Business reflects this commitment, allowing us to connect with students and parents in a more effective and transparent way. This step aligns with our vision for the future of digital education in Jordan, where every interaction is an opportunity to build stronger, more trusted relationships within our learning community." Priyam Bose, Global Head of GTM and Developer Products at Truecaller, added: "JoAcademy represents a new wave of digital-first education brands in Jordan, reimagining the student communication experience. By combining Business identity, localised context, and customer experience capabilities such as video caller ID and call me back, they're turning everyday conversations into opportunities that empower richer, more engaging communication. This association reflects a deep commitment to student experience and brand integrity. We're proud to support their mission to help set a new standard for student-first engagement in the region." Truecaller Customer Experience Solution is used by over 2,500+ businesses globally across industries to bring trust, identity, and efficiency to business communication. With this partnership, JoAcademy joins a growing network of organizations putting customer experience and verified engagement at the center of their communication strategy.

WK KELLOGG INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of WK Kellogg Co
WK KELLOGG INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of WK Kellogg Co

Business Wire

time15 hours ago

  • Business Wire

WK KELLOGG INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of WK Kellogg Co

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of WK Kellogg Co (NYSE: KLG) to The Ferrero Group. Under the terms of the proposed transaction, shareholders of WK will receive $23.00 in cash for each share of WK that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc
VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc

Business Wire

time15 hours ago

  • Business Wire

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Verona Pharma plc (NasdaqGM: VRNA) to Merck & Co., Inc. (NYSE: MRK). Under the terms of the proposed transaction, shareholders of Verona will receive $107.00 in cash for each share of American Depository Share that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store